|
Investors appear to wake up to potential of BioTime's Asthma iPhone app (BTX)
Seeking Alpha (registration) Thinly-traded small cap BioTime (BTX +16.1%) jumps on a 4x surge in volume in (what appears to be) belated response to the March 9 announcement by Mount Sinai's Icahn School of Medicine that it is launching a large-scale research study of asthma using … |
View full post on asthma – Google News